Montelukast in children with allergic rhinitis amid COVID‐19 pandemic

Chia Siang Kow; Syed Shahzad Hasan

doi:10.1111/apa.15491

Montelukast in children with allergic rhinitis amid COVID‐19 pandemic

Research output: Contribution to journal › Letter

Abstract

We complement the discussion by Brindisi et al. [1] on the management of allergic rhinitis in children amid novel coronavirus disease 2019 (COVID‐19) pandemic. Brindisi et al. [1] presented a well‐reasoned discussion on the use of intranasal corticosteroids and allergen immunotherapy in children with allergic rhinitis amid COVID‐19 pandemic where they recommend continuation of the former while withholding of the latter upon risk‐benefit assessment.

Original language	English
Pages (from-to)	2151
Number of pages	1
Journal	Acta Paediatrica, International Journal of Paediatrics
Volume	109
Issue number	10
Early online date	19 Jul 2020
DOIs	https://doi.org/10.1111/apa.15491
Publication status	Published - 1 Oct 2020

Access to Document

10.1111/apa.15491Licence: Unspecified

Link to publication in Scopus

Fingerprint Dive into the research topics of 'Montelukast in children with allergic rhinitis amid COVID‐19 pandemic'. Together they form a unique fingerprint.

Cite this

Kow, C. S., & Hasan, S. S. (2020). Montelukast in children with allergic rhinitis amid COVID‐19 pandemic. Acta Paediatrica, International Journal of Paediatrics, 109(10), 2151. https://doi.org/10.1111/apa.15491

@article{34b62378de8e4e5f9607709abb637065,

title = "Montelukast in children with allergic rhinitis amid COVID‐19 pandemic",

abstract = "We complement the discussion by Brindisi et al. [1] on the management of allergic rhinitis in children amid novel coronavirus disease 2019 (COVID‐19) pandemic. Brindisi et al. [1] presented a well‐reasoned discussion on the use of intranasal corticosteroids and allergen immunotherapy in children with allergic rhinitis amid COVID‐19 pandemic where they recommend continuation of the former while withholding of the latter upon risk‐benefit assessment.",

keywords = "Montelukast, Allergic rhinitis, COVID-19 Pandemic",

author = "Kow, {Chia Siang} and Hasan, {Syed Shahzad}",

year = "2020",

month = oct,

day = "1",

doi = "10.1111/apa.15491",

language = "English",

volume = "109",

pages = "2151",

journal = "Acta Paediatrica, International Journal of Paediatrics",

issn = "0803-5253",

publisher = "Wiley-Blackwell",

number = "10",

}

TY - JOUR

T1 - Montelukast in children with allergic rhinitis amid COVID‐19 pandemic

AU - Kow, Chia Siang

AU - Hasan, Syed Shahzad

PY - 2020/10/1

Y1 - 2020/10/1

N2 - We complement the discussion by Brindisi et al. [1] on the management of allergic rhinitis in children amid novel coronavirus disease 2019 (COVID‐19) pandemic. Brindisi et al. [1] presented a well‐reasoned discussion on the use of intranasal corticosteroids and allergen immunotherapy in children with allergic rhinitis amid COVID‐19 pandemic where they recommend continuation of the former while withholding of the latter upon risk‐benefit assessment.

AB - We complement the discussion by Brindisi et al. [1] on the management of allergic rhinitis in children amid novel coronavirus disease 2019 (COVID‐19) pandemic. Brindisi et al. [1] presented a well‐reasoned discussion on the use of intranasal corticosteroids and allergen immunotherapy in children with allergic rhinitis amid COVID‐19 pandemic where they recommend continuation of the former while withholding of the latter upon risk‐benefit assessment.

KW - Montelukast

KW - Allergic rhinitis

KW - COVID-19 Pandemic

UR - http://www.scopus.com/inward/record.url?scp=85089108588&partnerID=8YFLogxK

U2 - 10.1111/apa.15491

DO - 10.1111/apa.15491

M3 - Letter

VL - 109

SP - 2151

JO - Acta Paediatrica, International Journal of Paediatrics

JF - Acta Paediatrica, International Journal of Paediatrics

SN - 0803-5253

IS - 10

ER -